Firefly Neuroscience, Inc. (NASDAQ:AIFF) Stock Short Interest Report for September

Firefly Neuroscience, Inc. (NASDAQ:AIFF) was the recipient of a significant increase in short interest in September. As of September 30th, there was short interest totaling 1,098,284 shares, an increase of 265.0% from the September 15th total of 300,863 shares. Approximately 7.5% of the shares of the company are short sold. Based on an average trading volume of 14,576,030 shares, the short-interest ratio is currently 0.1 days.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on AIFF shares. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Firefly Neuroscience in a report on Friday, August 14th. Wall Street Zen downgraded shares of Firefly Neuroscience from a “hold” rating to a “sell” rating in a report on Saturday, August 15th. One equities research analyst has rated the stock with a Sell rating. According to MarketBeat.com, the stock has a consensus rating of “Sell”.

Institutional Investors Weigh In On Firefly Neuroscience

An institutional investor recently raised its position in Firefly Neuroscience stock. Cygnus Capital Advisors LLC lifted its position in shares of Firefly Neuroscience, Inc. (NASDAQ:AIFF) by 122.3% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 44,552 shares of the company’s stock after acquiring an additional 24,513 shares during the period. Cygnus Capital Advisors LLC owned approximately 0.28% of Firefly Neuroscience worth $54,000 as of its most recent filing with the Securities & Exchange Commission. 4.96% of the stock is currently owned by institutional investors.

Firefly Neuroscience Price Performance

Firefly Neuroscience stock traded down $0.05 during mid-day trading on Tuesday, hitting $1.07. The company’s stock had a trading volume of 48,389 shares, compared to its average volume of 4,269,676. The business has a 50 day moving average price of $1.18 and a 200-day moving average price of $1.46. Firefly Neuroscience has a 12 month low of $0.62 and a 12 month high of $3.15. The stock has a market cap of $16.79 million, a price-to-earnings ratio of -1.81 and a beta of 0.51.

Firefly Neuroscience (NASDAQ:AIFF) last issued its earnings results on Monday, August 10th. The company reported ($0.10) EPS for the quarter. Firefly Neuroscience had a negative return on equity of 90.17% and a negative net margin of 506.23%. The firm had revenue of $0.51 million during the quarter.

About Firefly Neuroscience

Firefly Neuroscience, Inc is a medical technology company focused on applying artificial intelligence to brain health and cognitive assessment. Its principal product is the Brain Network Analytics (BNA) platform, which analyzes electroencephalogram (EEG) data to generate insights into brain function and cognitive performance.

The BNA platform is designed to support clinicians, researchers and pharmaceutical companies in evaluating cognitive impairment and monitoring changes in brain health.